Fiji vs Trinidad and Tobago: New or unknown treatment history cases: Pulmonary, bacteriologically
Fiji
145
in 2023
Trinidad and Tobago
154
in 2023
Fiji rank
149th
Trinidad and Tobago rank
146th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Fiji
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 154 against 145 in Fiji, a difference of 9.
That makes Trinidad and Tobago's figure about 1.1 times Fiji's.
The two have swapped places 4 times across 11 shared years of data; in 2013 it was Trinidad and Tobago ahead.
Fiji ranks 149th and Trinidad and Tobago ranks 146th of 197 countries.
Across the 2 decades both report, Fiji averaged higher in 1 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Fiji | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 128.43 | 131.86 | 3.43 | Trinidad and Tobago |
| 2020s | 134.75 | 128 | 6.75 | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Fiji or Trinidad and Tobago?
- Trinidad and Tobago, at 154 against 145 in Fiji as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Fiji and Trinidad and Tobago?
- 9, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Fiji and Trinidad and Tobago?
- 11 years are reported by both, from 2013 to 2023.
- How do Fiji and Trinidad and Tobago rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Fiji ranks 149th and Trinidad and Tobago ranks 146th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.